These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9058310)
21. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Zen Y; Harada K; Sasaki M; Sato Y; Tsuneyama K; Haratake J; Kurumaya H; Katayanagi K; Masuda S; Niwa H; Morimoto H; Miwa A; Uchiyama A; Portmann BC; Nakanuma Y Am J Surg Pathol; 2004 Sep; 28(9):1193-203. PubMed ID: 15316319 [TBL] [Abstract][Full Text] [Related]
22. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients? Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867 [TBL] [Abstract][Full Text] [Related]
30. IgG4-negative autoimmune pancreatitis with sclerosing cholangitis and colitis: possible association with primary sclerosing cholangitis? Saeki K; Hozawa S; Miyata N; Nishizawa T; Soma H; Iwao Y; Kameyama K; Hibi T Intern Med; 2008; 47(10):943-8. PubMed ID: 18480579 [TBL] [Abstract][Full Text] [Related]
31. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD. Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470 [TBL] [Abstract][Full Text] [Related]
32. Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis? Pereira SP; Rhodes JM; Campbell BJ; Kumar D; Bain IM; Murphy GM; Dowling RH Clin Sci (Lond); 1998 Nov; 95(5):637-44. PubMed ID: 9791051 [TBL] [Abstract][Full Text] [Related]
33. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Seibold F; Slametschka D; Gregor M; Weber P Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629 [TBL] [Abstract][Full Text] [Related]
35. Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Boberg KM; Schrumpf E; Fausa O; Elgjo K; Kolmannskog F; Haaland T; Holter E Scand J Gastroenterol; 1994 Aug; 29(8):744-52. PubMed ID: 7973436 [TBL] [Abstract][Full Text] [Related]
36. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Lindberg BU; Broomé U; Persson B Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567 [TBL] [Abstract][Full Text] [Related]
37. Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis. Raina A; Yadav D; Regueiro M; Krasinskas AM; Saul MI; Sapienza DA; Binion DG; Hartman DJ Inflamm Bowel Dis; 2013 May; 19(6):1232-7. PubMed ID: 23619716 [TBL] [Abstract][Full Text] [Related]
38. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613 [TBL] [Abstract][Full Text] [Related]
39. Incidence, clinical presentation and pathological features of benign sclerosing cholangitis of unknown origin masquerading as biliary carcinoma. Fujita T; Kojima M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Ochiai A; Kinoshita T J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):139-46. PubMed ID: 19399359 [TBL] [Abstract][Full Text] [Related]